C
Claudius Mahr
Researcher at University of Washington
Publications - 116
Citations - 1696
Claudius Mahr is an academic researcher from University of Washington. The author has contributed to research in topics: Medicine & Ventricular assist device. The author has an hindex of 15, co-authored 76 publications receiving 780 citations. Previous affiliations of Claudius Mahr include University of Washington Medical Center.
Papers
More filters
Journal ArticleDOI
HVAD: The ENDURANCE Supplemental Trial.
Carmelo A. Milano,Joseph G. Rogers,Antone Tatooles,Geetha Bhat,Mark S. Slaughter,Emma J. Birks,Nahush A. Mokadam,Claudius Mahr,Jeffrey S. Miller,David W. Markham,Valluvan Jeevanandam,Nir Uriel,Keith D. Aaronson,T.A. Vassiliades,Francis D. Pagani,Endurance Investigators +15 more
TL;DR: The ENDURANCE Supplemental Trial confirmed that BP management is associated with reduced stroke rates in HVAD subjects, and the trial failed to demonstrate noninferiority of HVad versus control regarding the pre-specified primary endpoint.
Journal ArticleDOI
Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality.
A. Reshad Garan,Manreet Kanwar,Katherine L. Thayer,Evan H. Whitehead,Elric Zweck,Jaime Hernandez-Montfort,Claudius Mahr,Jillian L. Haywood,Neil M. Harwani,Detlef Wencker,Shashank S. Sinha,Esther E. Vorovich,Jacob Abraham,William W. O'Neill,Daniel Burkhoff,Navin K. Kapur +15 more
TL;DR: Use of complete PAC-derived hemodynamic data prior to MCS initiation is associated with improved survival from CS, and the complete PAC assessment group had the lowest in-hospital mortality than the other groups across all SCAI stages.
Journal ArticleDOI
Evaluation of a lateral thoracotomy implant approach for a centrifugal-flow left ventricular assist device: The LATERAL clinical trial.
Edwin C. McGee,Matthew R. Danter,Martin Strueber,Claudius Mahr,Nahush A. Mokadam,Georg Wieselthaler,Liviu Klein,Sangjin Lee,Theodore Boeve,Simon Maltais,G. Victor Pretorius,Eric Adler,T.A. Vassiliades,Anson Cheung +13 more
TL;DR: This prospective clinical trial provides validation that implantation of the HVAD system via the thoracotomy approach used in the LATERAL study represents a safe and effective alternative to median sternotomy in selected patients intended for a bridge-to-transplant indication.
Journal ArticleDOI
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock.
Katherine L. Thayer,Elric Zweck,Elric Zweck,Mohyee Ayouty,A. Reshad Garan,Jaime Hernandez-Montfort,Claudius Mahr,Kevin J. Morine,Sarah Newman,Lena Jorde,Jillian L. Haywood,Neil M. Harwani,Michele Esposito,Carlos Dávila,Detlef Wencker,Shashank S. Sinha,Esther Vorovich,Jacob Abraham,William W. O'Neill,James E. Udelson,Daniel Burkhoff,Navin K. Kapur +21 more
TL;DR: It is identified that venous congestion is common and identifies patients with CS at high risk for in-hospital mortality as well as the utility of SCAI stages and the impact of hemodynamic congestion on clinical outcomes.
Journal ArticleDOI
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
Paolo C. Colombo,Mandeep R. Mehra,Daniel J. Goldstein,Jerry D. Estep,Christopher T. Salerno,Ulrich P. Jorde,Jennifer A Cowger,Joseph C. Cleveland,Nir Uriel,Gabriel Sayer,Eric Skipper,Francis X Downey,Masahiro Ono,Robert Hooker,Anelechi C. Anyanwu,Michael M. Givertz,Claudius Mahr,Ia Topuria,Sami I. Somo,D. Crandall,Douglas A. Horstmanshof +20 more
TL;DR: The HM3 pump is associated with a marked reduction in stroke rates compared with the HMII device, with benefits observed in the long-term period (>6 months), and a stroke event significantly lowered 2-year postimplantation survival regardless of subtype or initial severity of neurological impairment.